Search results
Results from the WOW.Com Content Network
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies.
While the standard Impact Factor measures citations to journal articles published within a 2-year period, the 5-year Impact Factor evaluates citations to journal articles published within a 5-year period to provide a measure of a journal's longer-term influence.
According to the Journal Citation Reports, the journal has a 2020 impact factor of 39.397. [6]
Cancer Discovery Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2159-8274.
The impact factor for Cancer Discovery has more than tripled, and is now 39.397, according to Journal Citation Reports TM from Clarivate, 2021, released on Wednesday. “The incredible growth of the journal’s impact factor reflects Cancer Discovery’s importance to cancer researchers around the world,” said Foti. “The journal’s content ...
Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials.
The latest Impact Factor of the Cancer Discovery for 2024-2025 is 28.2. The Publicaiton fees (APC) is $4900. Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials.
» Journals of ESCI (except for fields of Arts and Humanities) are now ranked by JIF as the same with journals of SCIE and SSCI in the release of JCR 2023 (in 2024). Journals of AHCI and ESCI of Arts and Humanities are not ranked. » Open access (OA) journals are free for readers.
This focus on cutting-edge cancer science and medicine is reflected in the journal’s current impact factor of 39.397, which ranks sixth among more than 240 oncology journals. The AACR celebrated the journal’s decade of success with a series of initiatives: Landmark Articles.
Current Impact Factor for Cancer Discovery —which ranks sixth out of 229 journals in the Oncology category—according to the 2018 Journal Citation Report. Days from manuscript submission to first decision (on average).